Drug Safety Project

Copy the URL for use in an RSS reader:

The drug supply chain has become increasingly complex in recent years. Today’s prescription and over-the-counter remedies originate in factories all over the world, moving into American homes through supply chains that can involve numerous processing plants, manufacturers, suppliers, brokers, packagers, and distributors. This increases the risk that substandard or counterfeit medicines could reach patients and contributes to shortages of essential medicines. Pew’s work on drug safety helps to ensure a safe, reliable pharmaceutical manufacturing and distribution system.

Our Work

View All
  • Why Drug Compounding Is Not a Solution to High Prices

    Recent spikes in the price of certain off-patent medications have caused some legislators and health care professionals to advocate for using compounded drugs—drugs mixed by pharmacies—as a substitute for more expensive, FDA-approved medications. Though well-intentioned, this approach carries significant risks for patients and the sustainability of the drug approval system for the... Read More

  • Pew Continues to Urge Congress to Ensure Patient Safety

    As the debate over drug pricing persists on Capitol Hill, The Pew Charitable Trusts’ drug safety project is working to educate members of Congress about the dangers of allowing compounded drugs—drugs made by pharmacists—to serve as a low-cost alternative to FDA-approved medications. In advance of the U.S. House of Representatives’ Feb. 4 Oversight and Government Reform Committee hearing... Read More

  • Pew Urges Senate HELP Committee to Maintain Drug Safety Standards

    In advance of the Jan. 28 hearing, “Generic Drug User Fee Amendments: Accelerating Patient Access to Generic Drugs,” Allan Coukell, senior director of health programs at The Pew Charitable Trusts, sent a letter to members of the U.S. Senate Committee on Health, Education, Labor, and Pensions. In the letter, Coukell highlights the risks of relying on compounded drugs—medicines made by... Read More

Media Contact

Linda Paris

Manager, Communications, Medical Programs

202.540.6354